APRICOT: Anaesthesia PRactice In Children Observational Trial (APRICOT)

October 12, 2015 updated by: European Society of Anaesthesiology

APRICOT: Anaesthesia PRactice In Children Observational Trial - European Prospective Multicenter Observational Study: Epidemiology of Severe Critical Events in Paediatric Anaesthesia

The aims of the APRICOT study are:

  • To establish the incidence of severe critical events in children undergoing anesthesia in Europe.
  • To describe the differences in paediatric anaesthesia practice throughout Europe.
  • To study the potential impact of this variability on the occurrence of severe critical events (Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor).

Study Overview

Status

Completed

Conditions

Detailed Description

Despite the introduction of better-structured programmes for paediatric anaesthesia training and the development of some recommendations for paediatric anaesthesia services, the incidence of severe critical events in children is still unknown in Europe. Considering that the major life-threatening complications following general or regional anaesthesia are uncommon, it is therefore crucial to consider a large multinational, multicentre trial in order to establish a realistic statistical estimation and identify the risk factors for severe critical events. Thus, this prospective observational multicentre cohort study is designed to identify the incidence and potential risk factors of severe critical events in children undergoing anaesthesia in Europe.

The study aims to include all children from birth to 15 years old scheduled for an elective or urgent diagnostic or surgical procedure under sedation or general anaesthesia with or without regional analgesia or under regional anaesthesia. This represents the denominator dataset for calculation of the incidence of severe critical events, which is the primary aim of the study. The anaesthesiologist in charge will record the occurrence of selected severe critical events during and up to 60 minutes after anaesthesia or sedation AND requiring immediate intervention. These severe critical incidents include: Laryngospasm, Bronchospasm, Pulmonary aspiration, Drug error, Anaphylaxis, Cardiovascular instability, Neurological damage, Perianaesthetic cardiac arrest and postanaesthetic Stridor. The secondary endpoint is represented by the risk factors and the consequences for the occurrence of these severe critical events including in-hospital mortality established up to 30 days or at discharge. Relevant aspects of the child's medical and family history will be recorded.

Following sample size estimation, we plan to recruit at least 25 000 children over a period of two consecutive weeks including weekends and after-hours across the 30 European countries represented at the European Society of Anaesthesiology Council or part of geographical Europe. The 2-week recruitment period will be chosen by each site commencing on 15 March 2014.The last possible inclusion date will be decided by the Study Steering Committee depending on the recruitment rate. Participating hospitals will be provided with data acquisition sheets that enable anonymous standardized recording of all patients' parameters, which will be used by the local institution to fill in the electronic case report form (eCRF).

Descriptive statistical analysis will be performed for the primary endpoint (occurrence of severe critical events and 95% confidence interval). Univariate and multivariate analysis will be performed to test factors associated with the endpoint. Results of logistic regression will be reported as adjusted odds ratio (OR) with 95 % confidence intervals.

Study Type

Observational

Enrollment (Actual)

30000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Graz, Austria, A-8034
        • Medical University Graz
      • Bruxelles, Belgium, 1200
        • Cliniques Universitaires St Luc
      • Pula, Croatia, 52100
        • General Hospital Pula
      • Brno, Czech Republic, 61300
        • University children´s hospital
      • Odense, Denmark
        • Odense University Hospital
      • Tartu, Estonia, 51014
        • Tartu University Hospital
      • Oulu, Finland, 90220
        • Oulu University Hospital
      • Turku, Finland, 20521
        • Turku University Hospital
      • Lille, France
        • CHU Lille
      • Montpellier, France, 34000
        • Lapeyronie University Hospital
      • Leipzig, Germany, 04103
        • Universitaetsklinikum Leipzig
      • Nürnberg, Germany, 90419
        • Cnopf'sche Kinderklinik/Klinik Hallerwiese
      • Sankt Augustin, Germany, 53757
        • Asklepios Klinik Sankt Augustin GmbH - Department of Paediatric Anaesthesia
      • Gibraltar, Gibraltar, 11111
        • Gibraltar Health Authority, St. Bernard´s Hospital
      • Athens, Greece, 11527
        • Children Hospital P&A Kyriakoy
      • Dublin, Ireland, 12
        • Our Ladys Children's Hospital
      • Petah Tiqwa, Israel, 49202
        • Schneider Children's Medical Center of Israel
      • Genoa, Italy, 6100
        • Instituto Giannina Gaslini
      • Prishtina, Kosovo, 10000
        • University Clinical Center of Kosovo
      • Riga, Latvia, 1004
        • Children University Hospital
      • Vilnius, Lithuania, 8406
        • Vilnius Children Hospital
      • Msida, Malta, 2090
        • Mater Dei Hospital MSD
      • Maastricht, Netherlands
        • Maastricht University Medical Center MUMC
      • Oslo, Norway, 421
        • Oslo University Hospital, Rikshospitalet
      • Wroclaw, Poland, 50-556
        • Clinical University Hospital Department of Anaesthesiology and Intensive Care
      • Lisbon, Portugal, 1649-035
        • Centro Hospitalar Lisboa Norte - Hospital de Santa Maria
      • Bucharest, Romania, 41451
        • Spitalul de Copiin Maria Curie
      • Moscow, Russian Federation, 117997
        • Pirogov Russian National Research Medical University
      • Belgrade, Serbia, 11000
        • University Childrens Hospital
      • Banska Bystrica, Slovakia, 97409
        • Paediatric District Hospital
      • Ljubljana, Slovenia, 1000
        • University Klinical Centre Ljubljana
      • Esplugues de Llobregat, Spain, 8950
        • Hospital Sant Joan Déu
      • Gothenburg, Sweden, SE 41685
        • Queen Silvis Childrens Hospital Sahlgrens University Hospital
      • Geneva, Switzerland
        • Geneva University Hospitals
      • Luzern, Switzerland, 6000
        • Anästhesie Kinderspital Klinik für Anästhesie, Intensivmedizin, Rettungsmedizin und Schmerztherapie (KLIFAIRS) Luzerner Kantonsspital Spitalstrasse
      • Adana, Turkey, 01330
        • Cukurova University Faculty of Medicine
      • Kyiv, Ukraine, 4209
        • P.L.Shupyk National Medical Academy of Postgraduate Education, Municipal Children's Hospital #1
    • Scotland
      • Glasgow, Scotland, United Kingdom, G3 8SJ
        • Royal Hospital for Sick Children

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 15 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Children from birth to 15 years included admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or admitted for a diagnostic procedure under general anaesthesia (such as endoscopy, radiology…) or admitted out-of-hours for emergency procedures

Description

Inclusion Criteria:

  • Age: from birth to 15 years included
  • All children admitted for an inpatient or outpatient procedure under general anaesthesia with or without regional analgesia or under regional anaesthesia alone. This includes all kind of surgeries and procedures requiring anaesthesia and analgesia to be performed such as central venous access, burn care, cast, etc.,
  • Children admitted for a diagnostic procedure under sedation (performed by an Anaesthetist) or general anaesthesia (such as endoscopy, radiology (CT-scan, MRI), cardiac catheterisation and electrophysiology, PET-scan, radiotherapy, lumbar and bone marrow puncture, biopsies), diagnostic procedure under general anaesthesia (such as endoscopy, radiology…)
  • Children admitted for urgent or emergency procedure performed in- or out-of-hours.

Exclusion Criteria:

  • Children admitted directly from the intensive care units to the operating rooms
  • Anaesthesia procedures in the neonatal or paediatric intensive care units.
  • Age: All children aged ≥ 16 years.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of severe critical events
Time Frame: Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards

Incidence of the following severe critical events defined as any incident occurring during and up to 60 minutes after anaesthesia or sedation (PACU), requiring immediate intervention and that may lead to major disability and/or death:

  • Laryngospasm
  • Bronchospasm
  • Pulmonary aspiration
  • Drug error
  • Anaphylaxis
  • Cardiovascular instability
  • Neurological damage
  • Perianaesthetic Cardiac arrest
  • Postanaesthetic Stridor (in the PACU)
Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Risk factors for the occurrence of severe critical events
Time Frame: Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards
Assessment of risk factors will be achieved by collecting data on social and demographic data of the patients, family and child's medical history, presence of co-morbidities, details on anesthesia procedure, elective or emergency cases, level of experience of the anesthesiologist, postoperative prescriptions.
Children will be followed for the duration of their anaesthesia procedure and up to 60 minutes afterwards
Consequences of the critical events: irreversible damage, in-hospital mortality
Time Frame: in-hospital and up to 30 days
Consequences of critical events: no harm, minor sequelae, irreversible damage, in-hospital mortality (up to 30 days or discharge).
in-hospital and up to 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Walid Habre, M.D., University Hospital, Geneva
  • Study Director: Francis Veyckemans, M.D., Cliniques Universitaires St Luc asbl Brussels

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

January 1, 2015

Study Completion (Actual)

April 1, 2015

Study Registration Dates

First Submitted

May 28, 2013

First Submitted That Met QC Criteria

June 13, 2013

First Posted (Estimate)

June 17, 2013

Study Record Updates

Last Update Posted (Estimate)

October 14, 2015

Last Update Submitted That Met QC Criteria

October 12, 2015

Last Verified

October 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anaesthesia

3
Subscribe